TipRanks
Go Ultimate55% OFF

Voyager Therapeutics (VYGR) Revenue

Voyager Therapeutics Revenue

Voyager Therapeutics had a revenue of 3.17M in the quarter ending Jun 30, 2026, with 22.06%. This bring the company's revenue in the last twelve months to 34.46M, Decreased 5.58%. In the fiscal year ending Dec 31, 2025, Voyager Therapeutics had annual revenue of 40.37M with -49.53% growth.

Revenue (ttm)
34.46M
Revenue Growth
-19.07%
P/S Ratio
2.63
Revenue/Employee
$286,340
Employees
141
Market Cap
$105.98M

Revenue Chart

Voyager Therapeutics Revenue - Annual

050M100M150M200M250M300M10.13M7.62M104.39M171.13M37.41M40.91M250.01M80.00M40.37M201720182019202020212022202320242025
Revenue History
Download to Excel
VYGR revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202540.37M-39.63M-49.53%
Dec 31, 202480.00M-170.01M-68.00%
Dec 31, 2023250.01M209.10M511.16%
Dec 31, 202240.91M3.49M9.33%
Dec 31, 202137.41M-133.71M-78.14%
Dec 31, 2020171.13M66.74M63.93%
Dec 31, 2019104.39M96.77M1270.14%
Dec 31, 20187.62M-2.52M-24.82%
Dec 31, 201710.13M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
VYGR34.46M
GALT0.00
RNAC1.48M
SLN614.29K
TNYA1.33M
KYTX0.00